ImmunoGen Reports Recent Progress and Third Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall St mixed as Middle East tensions eclipse tech strength
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Immunogen (IMGN) Announces In-Line Q3 EPS, Reports $245.8M of Cash and Cash Equivalents
October 29, 2021 6:37 AM EDTImmunogen (NASDAQ: IMGN) reported Q3 EPS of ($0.18), in-line with the analyst estimate of ($0.18). Revenue for the quarter came in at $9.2 million versus the consensus estimate of $19.03 million.
For earnings history and earnings-related data on Immunogen (IMGN) click here.
... More